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Abstract
Background: Extracellular adenosine 5'-triphosphate (ATP) is an endogenous signaling molecule
involved in multiple biological phenomena, including inflammation. The effects of extracellular ATP
in the lung have not been fully clarified. This study examined 1) the biological roles of extracellular
ATP in the pathogenesis of lung inflammation and 2) the possibility of involvement of extracellular
ATP in mechanical ventilation-induced lung injury.
Methods: The effects of intratracheal ATP on lung permeability, edema or lung inflammation were
assessed by measurements of the lung wet-to-dry weight ratio and lung permeability index,
immunohistochemistry and expression of key cytokines by real-time polymerase chain reaction.
The ATP concentration in broncho-alveolar lavage (BAL) fluid from mice mechanically ventilated
was measured by luciferin-luciferase assay. The suppressive effects of a P2 receptor antagonist on
ventilator-induced lung inflammation were also examined.
Results: ATP induced inflammatory reactions in the lung mainly via the ATP-P2Y receptor system.
These reactions were alleviated by the co-administration of a specific P2 receptor antagonist.
Mechanical ventilation with a large tidal volume caused lung inflammation and increased the ATP
concentration in BAL fluid. P2 receptor antagonism partially mitigated the inflammatory effects of
large tidal volume ventilation.
Conclusion: Our observations suggest that the ATP-P2Y receptor system is partially involved in
the pathogenesis of ventilator-induced lung injury.
Background
Acute lung injury and acute respiratory distress syndrome
are major causes of acute respiratory failure, and are char-
acterized by pulmonary edema, neutrophil infiltration
with hemorrhage and increased production of inflamma-
tory mediators [1]. Although mechanical ventilation is
indispensable for the survival of critically ill patients pre-
senting with acute lung injury (ALI)/acute respiratory dis-
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tress syndrome (ARDS) [2], clinical trials have shown that
improperly delivered mechanical ventilation may worsen
or cause lung injury [3]. Lungs exposed to ineffective ven-
tilator settings often develop diffuse alveolar injury [4],
pulmonary edema [5] and activation of inflammatory
cells [6]. The development of ventilator-induced lung
injury (VILI) has been closely related to an increased pro-
duction of pro-inflammatory cytokines [7], and to the
leakage of inflammatory mediators into the systemic cir-
culation [8]. Ventilation with a small tidal volume lowers
the pulmonary and systemic concentrations of inflamma-
tory mediators [9], and has beneficial effects in patients
with ALI/ARDS [10], as well as in patients without lung
disease undergoing mechanical ventilation [11].
Adenosine 5'-triphosphate (ATP), a nucleotide normally
present in the cytoplasm, plays a prominent role in energy
metabolism. Besides its intracellular role, extracellular
ATP is involved in the regulation of several biological
processes such as nociception [12], renal cell growth [13],
and bone remodeling [14] via P2 purinergic receptors in
the cell surface. Purinergic receptors are present in the
lung [15], and the alveolar epithelial cells release ATP in
response to various stimuli [16]. Bronchial hyper-respon-
siveness in asthmatic patients is triggered by intrinsic ATP,
suggesting an important role played by ATP in the inflam-
mation of the airways [17]. The purinergic system partici-
pates in the mechano-sensory functions of the urinary
system [18,19] and of the pain- and stretch-sensing neu-
rons [20]. Since mechanical stress causes the release of
ATP by the lung epithelial cells [21], and since ATP stim-
ulates the release of inflammatory cytokines by cultured
macrophages, dendritic cells, or both [22-26], the purin-
ergic system may be involved in the development of
inflammatory reactions from mechanical stress in the
lung.
To define the role played by extracellular ATP in the
pathogenesis of lung inflammation due to mechanical
ventilation, we 1) examined the effects of ATP exoge-
nously instilled in the airways, 2) measured the concen-
trations of extracellular ATP in broncho-alveolar lavage
(BAL) fluid after mechanical ventilation, 3) determined
whether a purinergic receptor antagonist can alleviate the
lung injury caused by mechanical ventilation, and 4) doc-
umented the expression of the P2Y2 and P2Y4 ATP recep-
tors in lung tissue. Some of the results of these studies
have been previously reported in the form of an abstract
[27].
Methods
Biochemicals
Adenosine 5'-triphosphate (ATP), selective P2Xs, P2Y2
and P2Y4  antagonist pyridoxal-5'-phosphate-6-azophe-
nyl-2', 4 '-disulfonic acid (PPADS), selective P2Y agonist
uridine 5'-triphosphate (UTP) and selective P2X agonist
α,β-methylene ATP (α,β-MeATP) were obtained from
Sigma-Aldrich (St. Louis, MO).
Animals
All experimental procedures and protocols were approved
by the Animal Care Committee of the Kyoto Prefectural
University of Medicine. The experiments included 308
male, specific, pathogen-free, 6- to 8-week-old Institute of
Cancer Research mice (Japan S.L.C. Co. LTD., Shizuoka,
Japan).
ATP instillation
Under general anesthesia with inhaled sevoflurane, the
mice were intubated with a 24 gauge, modified animal
gavage needle (Popper & Sons, Inc., New Hyde Park, NY).
First we performed a 6–48-h time course study and a 100–
200-mM dose-response study to determine the proper
response time and amount of ATP instillation. In some
mice, 50 μl of 100 mM ATP was instilled into the left main
bronchus via the needle. Other mice received a) a mixture
of 100 mM ATP and 50 mM PPADS, b) 200 mM UTP, or
c) 200 mM α,β-MeATP. Control mice received the same
amount of saline. Mice recovered from the anesthesia
within 1 min, were returned to their cages, and were pro-
vided with unrestricted food and water. They were
allowed to survive for 60 min or 24 h, then sacrificed with
deep sevoflurane anesthesia for further experiments.
Wet-to-dry lung weight ratio
The lung wet-to-dry (W/D) weight ratio was used as an
index of lung water accumulation after the instillation of
ATP. To measure the total amount of lung water, the ani-
mals were dissected under deep sevoflurane anesthesia,
and the lung weight was measured immediately after its
excision (wet weight). The lung tissue was then dried in an
oven at 60°C for 5 days and re-weighed as dry weight. The
W/D weight ratio was calculated by dividing the wet by
the dry weight as described previously [28].
Permeability index
The permeability index, an index of alveolar epithelial
and endothelial permeability [29], was calculated by
injecting 100 μl containing 25 μg of human serum albu-
min intravenously, via a tail vein, 23 h after the instilla-
tion of ATP. The mice were anesthetized with sevoflurane
1 h after the injection, blood was sampled from the infe-
rior vena cava, and BAL was twice performed with 0.5 ml
of normal saline. To avoid the contamination of blood
into BAL fluid, the catheter was inserted into the trachea
and BAL was performed through the catheter. The total
recovery volume of lavage fluid was regularly in the range
from 0.8 to 0.9 ml in each mouse. The whole blood and
BAL fluid were centrifuged at 1,000 g for 10 min at 4°C,
to obtain plasma and cell-free BAL fluid. The plasma sam-Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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ples and the cell-free BAL fluid supernatant were kept at -
80°C until further analysis. The concentration of human
albumin in each solution was determined by enzyme-
linked immunosorbent assay, using a human serum albu-
min kit (Cygnus Technologies, Southport, NC). The per-
meability index was calculated as the human albumin
concentration in BAL fluid/plasma ratio × 1,000.
Histological examinations
The mice were sacrificed 24 h after the instillation of ATP,
and the left lung was excised, fixed with 4% paraformal-
dehyde for 6 h, embedded in paraffin, and sectioned in 4
μm thick slices, which were stained with hematoxylin and
eosin. Immunohistochemical staining was also carried
out to detect the distribution of P2Y2 and P2Y4 receptors
in the lung of untreated mice. The lung sections were
deparaffinized in toluene and hydrated by passage
through decreasing concentrations of ethanol solutions.
The antigen was activated by autoclave at 121°C for 15
min, immersed in 10 mM sodium citrate buffer followed
by a 20-min cool-down, and incubated with rabbit anti-
P2Y2 antibodies (1:300, AlphaGenix, Sioux Falls, SD) or
rabbit anti-P2Y4 receptor antibodies (1:100, Biomol Inter-
national, L.P., Plymouth Meeting, PA) at 4°C for 3 days.
Staining was performed using the biotin-streptavidin
technique and developed with diaminobenzidine. Coun-
terstaining was performed with methyl green.
BAL fluid analyses
The mice were sacrificed 24 h after the instillation of ATP,
and the left lung was twice lavaged with 0.5 ml of saline.
In all of the mice, the recovery volume was >0.8 ml. After
centrifugation of the BAL fluid at 400 g for 10 min at 4°C,
the cell pellets were resuspended in 1 ml of saline. The
total number of cells in BAL fluid was counted with a
hemocytometer. Cytospins were prepared from resus-
pended BAL fliud cells, using a Shandon Cytospin® 3
Cytocentrifuge (Shandon, Astmoore, UK). Cell differen-
tials were counted on the slides stained with Diff-Quik
(Sysmex, Kobe, Japan).
Expression of cytokine mRNA
Quantitative real-time reverse transcription (RT) polymer-
ase chain reaction (PCR) was performed to measure the
relative levels of expression of lung inflammatory
cytokine gene. Total RNA was extracted from the left lung
homogenates, using the TRIzol®  reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer's recom-
mendations. The RNA concentration was measured by
spectrophotometry. First-strand cDNA was synthesized
from total RNA using a SuperScript Platinum® Two-Step q
RT PCR reaction Kit (Invitrogen, Carlsbad, CA) as
instructed by the manufacturer. PCR primers for target
gene were purchased from Takara Bio Inc. (Otsu, Shiga,
Japan). Relative mRNA levels were measured with a
SYBER green detection system on an ABI 7300 Real-Time
PCR system (Applied Biosystems, Foster City, CA). All
samples were measured in triplicate. We measured the
expression levels of macrophage inflammatory protein-2
(MIP-2), tumor necrosis factor-α (TNF-α), interleukin-6
(IL-6) and IL-1β. The relative amount of expression of
each gene was calculated as a ratio compared with the ref-
erence gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
Mechanical ventilation
The mice were anesthetized with inhaled sevoflurane and
intraperitoneal injection of pentobarbital (Abbot Labora-
tories, North Chicago, IL), 50 mg/kg. A vertical midline
cervical incision was used for cannulation of the trachea
with a blunt 18-gauge endotracheal tube. Immediately
after the cannulation, the mice were connected to a model
683 mechanical ventilator (Harvard Apparatus, South
Natick, MA) for the delivery of lung injurious ventilation
with a 40-ml/kg tidal volume, or to a HSE-Harvard Mini-
Vent (Hugo Sachs Elektronik-Harvard Apparatus GmbH,
March-Hugstetten, Germany) for room air ventilation
with an 8-ml/kg tidal volume, for 60 min. Positive end-
expiratory pressure was set at 0 cmH2O for large, and 3 cm
H2O for small tidal volumes ventilation. We chose a 40-
mg/kg tidal volume for injurious ventilation, since our
preliminary study showed no significant change of lung
W/D weight ratio by the ventilation with 10–20 ml/kg
tidal volume (data not shown). The control group under-
went tracheotomy only. In some mice, both lungs were
excised for measurement of the W/D weight ratio and
analysis of cytokine mRNA expression. Others were proc-
essed to measure the alveolar ATP concentration in BAL
fluid. Some mice received 60 μl of either sterile saline or
50 mM PPADS into the lung, 60 min before the onset of
mechanical ventilation.
ATP assay in BAL fluid
Following mechanical ventilation, 1 ml of sterile saline
was slowly instilled from the endotracheal tube, and BAL
fluid was collected, centrifuged at 800 g for 10 min at 4°C
to prevent cytolysis, and the supernatant was used for the
ATP assay. ATP in BAL fluid was measured by a luciferin-
luciferase assay (Toyo Ink Co., Tokyo, Japan). The relative
light intensity was recorded in a Lumat LB9507 luminom-
eter (Berthold Technologies GmbH & Co. KG, Wildbad,
Germany).
Statistical analyses
All data are presented as means ± SEM. Between-groups
comparisons were made by one-way analysis of variance
with the parametric Student-Newman-Keuls multiple
comparison post-test or the non-parametric Kruskal-Wal-
lis test with Dunn's multiple comparison post-test. Instat
3 software (GraphPad Software Inc. San Diego, CA) wasRespiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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used for all analyses. p values < 0.05 were considered sta-
tistically significant.
Results
Effect of ATP instillation on the lung water content
Following the instillation of 50 μl of 100 mM ATP, the
lung W/D weight ratio increased within 12 h after treat-
ment, up to 24 h, and returned to baseline within 48 h
(Figure 1A). Figure 1B shows the dose-dependent effects
of ATP on the lung W/D weight ratio at 24 h following the
instillation. In animals treated with >100 mM of ATP, the
increase in W/D weight ratio was significant. In contrast,
treatment with saline at a pH = 3.0 (similar to the ATP
solution) did not increase the W/D weight ratio (data not
shown).
In order to determine whether the effect of ATP was medi-
ated by P2 purinoreceptors, we administered PPADS, a
ATP-induced lung edema and its mitigation by P2 receptor antagonist Figure 1
ATP-induced lung edema and its mitigation by P2 receptor antagonist. A. Time course of wet-to-dry (W/D) weight 
ratio following the instillation of ATP. 50 μl of 100 mM ATP was instilled into the left lung. The W/D weight ratio was calcu-
lated 6–48 h after the instillation. n = 5–7 mice in each group; *p < 0.05 vs. pre-treatment. B. Dose-dependency test. The W/D 
weight ratio was calculated 24 h after the 50 μl of 100–200 mM ATP instillation. The W/D weight ratio increased in a dose-
dependent manner and the difference reached statistical significance at 100 mM of ATP. n = 11–15 mice in each group; *p < 
0.05 vs. saline. C. Mitigation of ATP-induced lung water accumulation by P2 receptor antagonism. The increase of W/D weight 
ratio induced by instillation of 100 mM ATP was attenuated by the co-administration of 50 mM PPADS and 100 mM ATP. The 
W/D weight ratio was measured 24 h after the instillation. n = 5–9 mice in each group; *p < 0.05 vs. control; #p < 0.01 vs. 
ATP. D. Mitigation of ATP-induced lung permeability by P2 receptor antagonism. Increase in permeability of alveolar epithelial 
and endothelial cells by instillation of 100 mM ATP. This effect was inhibited by the co-administration of 50 mM PPADS and 
100 mM ATP. The permeability index was calculated 24 hr after the instillation. n = 7 mice in each group, *p < 0.05 vs. control; 
#p < 0.05 vs. ATP.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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specific antagonist against the P2X and P2Y receptors [15],
along with ATP. The simultaneous administration of
PPADS, 50 mM, and ATP attenuated the increase in W/D
weight ratio induced by ATP (Figure 1C).
The instillation, 24 h before the assay, of ATP, 100 mM,
caused a significant increase in the albumin permeability
index, a measure of the permeability of alveolar epithelial
and endothelial cells (Figure 1D). The concomitant
administration of PPADS and ATP inhibited the effects of
ATP.
ATP-induced inflammatory response in the lung
On histological examination, 24 h after the instillation of
ATP, 100 mM, the thickness of the alveolar walls, the
amount of alveolar hemorrhage and the numbers of neu-
trophils and macrophages infiltrating the lung were
increased (Figure 2A). In contrast, the instillation of saline
did not induce this inflammatory response in the control
group. The histological derangement of alveolar architec-
ture was partially mitigated by the simultaneous adminis-
tration of PPADS and ATP. Therefore, the total number of
cells in the BAL fluid was significantly increased in the
mice instilled with 100 mM ATP 24 h before the assay.
The differential cell counts showed that there were
increased numbers of macrophages and neutrophils in
ATP-treated mice (Figure 2B). The co-administration of
PPADS limited the neutrophil infiltration, though the
decrease was not statistically significant.
Real-time PCR revealed that the induction of multiple
inflammatory cytokines and chemokines is involved in
the pulmonary inflammatory reaction induced by ATP.
Exogenous ATP increase significantly the expression of
MIP-2 and IL-6 mRNA within 60 min after its intratra-
cheal instillation, and the simultaneous administration of
PPADS and ATP inhibited the expression of these genes
(Figure 3A). There was no significant change in the expres-
sion of TNF-α mRNA (data not shown). The instillation of
ATP caused a significant increase in the expression of MIP-
2, IL-6 and TNF-α mRNA within 24 h. The simultaneous
administration of PPADS and ATP inhibited the induction
of MIP-2 and expression of the IL-6 gene, however not
that of TNF-α. The expression of IL-1β mRNA in the lung
tissue, by contrast, was not modified by treatment with
ATP (Figure 3B).
Mediation of the effect of ATP on lung inflammation by 
the P2Y receptor
To identify the signal transduction of ATP-induced lung
inflammation, we examined the effects caused by the
instillation of UTP, an ATP analog selective for P2Y recep-
tors, and α,β-MeATP, selective for P2X receptors, on the
lung status. The instillation of UTP, 200 mM, caused a
similar infiltration of inflammatory cells as that caused by
ATP (Figure 4A). On the other hand, the instillation of
α,β-MeATP caused no significant histological change in
the lung. The instillation of UTP also induced a significant
increase in W/D weight ratio (control; 4.781 ± 0.050,
UTP; 5.065 ± 0.069, p = 0.0063) and permeability index
(control; 0.4600 ± 0.0915, UTP; 0.8018 ± 0.2003, p =
0.0285).
Immunohistochemistry identified P2Y2 and P2Y4 receptor
expressions in bronchiolar epithelial cells, alveolar walls
and alveolar macrophages in the lung of untreated mice
(Figure 4B).
ATP secretion induced by large volume ventilation
On histological examination, the thickness of the alveolar
wall was increased and an invasion by inflammatory cells
was observed in the lung of the group ventilated with a
large tidal volume (Figure 5A). The lung W/D weight ratio
increased significantly following 60 min of mechanical
ventilation with the 40-ml/kg tidal volume, while no
apparent change was observed in the group ventilated
with the 8-ml/kg tidal volume (Figure 5B). The cytokine
mRNA assay revealed a significant increase in the expres-
sion of MIP-2 and IL-6 mRNA that was limited to the
lungs of mice ventilated with large tidal volumes (Figure
5C). These observations confirmed that mechanical venti-
lation with a large tidal volume constituted a suitable
model of lung injury.
Compared to the spontaneously breathing control mice,
the ATP concentration in BAL fluid, measured photomet-
rically, was significantly increased in the animals exposed
to the large tidal volume, but not those ventilated with a
small tidal volume (Figure 5D).
Mitigation of the ventilation-induced pulmonary 
inflammatory response by PPADS
To confirm the involvement of the purinergic system in
VILI, we instilled 60 μl of 50 mM PPADS or saline before
the onset of mechanical ventilation. This administration
of PPADS caused a significant blockade of the expression
of IL-6 in the lung (Figure 6C), though did not limit the
increase in the W/D weight ratio (Figure 6A), expression
of MIP-2 (Figure 6B) and permeability index (data not
shown).
Discussion
ATP is believed to act in the intercellular signal transduc-
tion as a "purinergic system" in multiple organs, and is
involved as an energy source in cellular metabolism. In
the present study, exogenously applied ATP caused an
inflammatory reaction by activating the P2Y purinergic
receptors. The extracellular concentrations of ATP in the
alveolar space increased as a result of the injury inflicted
by mechanical ventilation with a large tidal volume, sug-Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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Infiltration of inflammatory cells after instillation of ATP Figure 2
Infiltration of inflammatory cells after instillation of ATP. A. Hematoxilin-eosin staining of the lung. The instillation of 
ATP increased the thickness of the alveolar walls, and caused alveolar hemorrhages and infiltration of neutrophils and macro-
phages in 24 h. These histological changes were not enough mitigated by the simultaneous administration of PPADS. Bars = 100 
μm in the upper panels, and = 50 μm in the lower panels. B. Total and differential cells count in BAL fluid after instillation of 
ATP. The instillation of 100 mM ATP caused significant increase in total cells, macrophages and neutrophils in BAL fluid in 24 h. 
n = 8 mice in each group; *p < 0.05 vs. control.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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Induction of expression of inflammatory cytokines by instillation of ATP Figure 3
Induction of expression of inflammatory cytokines by instillation of ATP. A. Inflammatory cytokine expression in 
early phase. The instillation of ATP increased significantly the mRNA expression of MIP-2 and IL-6 in 60 min. PPADS limited 
the increase in the expression of these genes. n = 8 mice in each group; *p < 0.05 vs. control; #p < 0.05 vs. ATP. B. Inflamma-
tory cytokine expression in 24 h. The instillation of ATP increased significantly the mRNA expression of MIP-2, IL-6 and TNF-
α, but not of IL-1β. PPADS limited the increase in the expression of MIP-2 and IL-6 gene. n = 8 mice in each group; *p < 0.05 
vs. control; #p < 0.01 vs. ATP.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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Lung inflammation caused by P2Y and P2X selective agonist Figure 4
Lung inflammation caused by P2Y and P2X selective agonist. Hematoxilin-eosin staining of the lung 24 h after the 
instillation of UTP or α,β-MeATP. Infiltration of inflammatory cells, increased thickness of the alveolar walls and alveolar hem-
orrhages were observed in the 200 mM UTP-treated lungs. However, there was no evident derangement in the 200 mM α,β-
MeATP-treated lungs. Bars = 100 μm in the upper panels, and = 50 μm in the lower panels. B. Immunohistochemistry of the 
P2Y2 and P2Y4 receptors. P2Y2 and P2Y4 receptors were detected in bronchiolar epithelial cells, alveolar walls and alveolar 
macrophages in the lung of untreated mice. Bars = 100 μm in the upper panels, and = 50 μm in the lower panels.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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Lung inflammation caused by large tidal volume mechanical ventilation Figure 5
Lung inflammation caused by large tidal volume mechanical ventilation. A. Histological analysis showed a preserved 
lung parenchymal structure in the group ventilated with an 8-ml/kg tidal volume for 60 min. In contrast, an increased thickness 
of the alveolar wall and inflammatory cell invasion were observed in the group ventilated with 40-ml/kg tidal volume. Bars = 
100 μm in the upper panels, and = 50 μm in the lower panels. B. Mechanical ventilation with a large tidal volume increased the 
lung W/D weight ratio significantly. This was not observed in the group mechanically ventilated with a small tidal volume. n = 8 
mice in each group; *p < 0.05 vs. control and 8 ml/kg. C. The expression of MIP-2 and IL-6 gene was markedly increased in the 
lungs mechanically ventilated with a large tidal volume. n = 8 mice in each group; *p < 0.05 vs. control and 8 ml/kg. D. The ATP 
concentration in BAL fluid was significantly higher in mice ventilated with a large tidal volume than in non-ventilated control 
mice. n = 4–8 mice in each group; *P < 0.05 vs. control.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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gesting an important role played by the purinergic system
in the development of mechanical VILI.
Facilitation of lung inflammation by extracellular ATP
Following the intratracheal instillation of exogenous ATP,
we observed increases in the W/D weight ratio and perme-
ability index. Since the W/D weight ratio and the permea-
bility index reflect, respectively, the lung water content
and the vascular permeability status, our observations
indicate that vascular permeability and lung water con-
tent, both manifestations of lung inflammation, were
both increased. In the range that we tested, the action of
ATP was dose-dependent, beginning 6 h after the instilla-
tion and persisting for up to 24 h thereafter. This was asso-
ciated, histologically, with the aggregation of
inflammatory cells in the alveolar tissue. These changes
are attributed to a biological effect of ATP mediated by
specific receptors, rather than to chemical or physiological
effects exerted by the ATP solution, since administration
of pH-adjusted saline had no effect on the lung edema or
alveolar histology. PPADS alleviated ATP-induced lung
edema and cytokine expression but it failed to inhibit the
accumulation of inflammatory cells. PPADS is a puriner-
gic receptor antagonist that acts on P2Y2 and P2Y4 [15],
while extracellular ATP has been observed to induce
chemotaxis of microglia, which acts as an innate immune
system in the central nervous system, mediated by the
P2X4 and P2Y12 receptors [30]. Thus, the differential effect
of ATP might reflect a heterogeneous receptor signaling of
ATP-mediated lung inflammation. While the activation of
immune cell and consequent lung injury is mediated by
P2Y2 and P2Y4, the migration of inflammatory cells is
mediated by other purinergic receptors.
Previous in vitro studies have shown that extracellular ATP
stimulates monocytes/macrophages or dendritic cells to
release inflammatory cytokines, such as IL-1β [22,24-26]
and TNF-α [23]. Our PCR study revealed that ATP
increased the expression levels of IL-6, TNF-α and MIP-2,
but not of IL-1β mRNA. This absence of increase in IL-1β
mRNA level following ATP treatment is consistent with
previous reports of a post-transcriptional regulation of IL-
1β by ATP [22,31]. In addition to its pro-inflammatory
activity, ATP regulates the status of fluids in lung tissue,
Figure 6
Effects of P2 receptor antagonist on lung inflammation caused  by large tidal volume mechanical ventilation Figure 6
Effects of P2 receptor antagonist on lung inflamma-
tion caused by large tidal volume mechanical ventila-
tion. A. The pre-instillation, 60 min before the onset of 
mechanical ventilation, of PPADS (60 μl of 50 mM) attenu-
ated the increase in W/D weight ratio caused by large tidal 
volume mechanical ventilation for 60 min, though the differ-
ence was not statistically significant. n = 16 mice in each 
group; *p < 0.05 vs. control. B. Pre-treatment with PPADS 
did not significantly inhibit the induction of MIP-2 mRNA fol-
lowing large tidal volume ventilation. n = 8 mice in each 
group; *p < 0.05 vs. control. C. Pre-treatment with PPADS 
inhibited the induction of IL-6 following large tidal volume 
ventilation. n = 8 mice in each group; *p < 0.05 vs. control; 
#p < 0.05 vs. saline.Respiratory Research 2008, 9:79 http://respiratory-research.com/content/9/1/79
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stimulating the release of mucin and surfactant from
bronchial epithelial and type II alveolar epithelial cells
[32,33]. Therefore, the increase in lung edema that fol-
lowed the instillation of ATP was the mixed consequence
of an inflammatory reaction and a derangement of fluid
exchange, both of which are due to the direct action of
extracellular ATP.
Involvement of the P2Y receptor in ATP-induced lung 
inflammation
The two subtypes of the purinergic receptor family are
P2X, which is coupled with the ion channel, and P2Y,
which activates the intracellular G-protein. To identify the
receptor primarily involved in ATP-induced lung injury,
we used the ATP analogue, α,β-MeATP, which acts selec-
tively against the P2X receptor, and UTP, which acts selec-
tively against the P2Y receptor [34]. While UTP induced
an inflammatory response similar to ATP, α,β-MeATP had
no apparent effect on the lung, suggesting that the activa-
tion of the P2Y receptor system was sufficient to promote
lung injury. Among several subtypes of P2Y receptors,
P2Y2  and P2Y4 are the most abundant in lung tissue
extracts [15] and are expressed on alveolar macrophages
in BAL fluid [35]. Our immunohistochemical analysis
identified the expression of P2Y2 and P2Y4 in bronchiolar
and alveolar epithelial cells and alveolar macrophages,
which are both believed to be sources of inflammatory
cytokines during acute lung injury [36,37]. Consistent
with these observations, PPADS, a selective purinergic
antagonist against P2X, P2Y2  and P2Y4, mitigated the
inflammatory effects of the instillation of ATP. Therefore,
ATP might activate epithelial cells, macrophages or both
via P2Y2 and P2Y4 receptors to promote the production of
inflammatory cytokines associated with lung injury.
Involvement of ATP in mechanical lung injury
Worsening or induction of acute lung injury by mechani-
cal ventilation is known as "VILI, and also as "ventilator-
associated" lung injury. VILI is characterized by an
increased alveolar permeability, pulmonary edema, infil-
tration of neutrophils, and the release of inflammatory
mediators [38,39]. An increased cytokine expression
accompanied by migration of inflammatory cells was
observed in lungs ventilated with large tidal volumes. The
concentration of ATP in BAL fluid was markedly increased
under these circumstances, consistent with the release of
ATP in response to alveolar epithelial cell stretch in vitro
[40], or the increase in ATP or purine concentrations in
BAL fluid after mechanical ventilation in vivo [41-43]. The
concentration of ATP did not increase after lung protective
ventilation, suggesting an essential role of ATP in mediat-
ing VILI. Alveolar epithelial cells or macrophages can pro-
duce pro-inflammatory cytokines such as IL-6, IL-8 and
TNF-α when stretched in vitro [44-47] and promote VILI
[48,49]. Since the instillation of ATP induced proinflam-
matory cytokines, ATP-P2Y signaling might act as a bio-
logical sensor that translates mechanical stimuli into
production of cytokines. Yoshikawa et al. have shown that
lung edema induces VILI independently [50]. Since exog-
enous ATP directly controls the fluid status in the lung, the
lung edema caused by ATP might be another mechanism
of VILI.
The antagonism of ATP-P2Y signaling by PPADS blocked
the production of IL-6 induced by mechanical ventilation,
illustrating the, at least partial, involvement of ATP signal-
ing in the mechano-transduction and pathophysiology of
VILI. PPADS prevented neither the production of MIP-2,
nor the changes in W/D weight ratio and permeability
index following ventilation. This might reflect the com-
plexity of pathogenesis of VILI, even in ATP signaling.
In contrast to our observations, a recent study found that
intravenous ATP enhanced endothelial integrity and alle-
viated LPS-induced lung injury in mice [51]. In vitro stud-
ies have shown that the biological effects of ATP are
multiple, including monocyte chemotaxis [52] and
enhanced endothelial integrity [53]. Discrepancies
between our observations and those made by Kolosova et
al. are probably attributable to a multimodal effect of
ATP. We injected ATP intratracheally, which might have
had a direct effect on the alveolar tissue. The limited effi-
cacy of PPADS in the prevention of mechanical lung
injury is, therefore, likely to reflect multiple and site-spe-
cific biological effects of ATP.
We found, in this study, that considerable amounts of ATP
are released into the alveolar space following injurious
ventilation, which are sufficient to promote an alveolar
inflammatory reaction. The efficacy of ATP antagonism in
the treatment of VILI should be tested in a clinically-ori-
ented animal model.
Conclusion
In the present study, we found that extracellular ATP pro-
motes lung inflammation in mice in vivo, and that the
ATP-P2Y receptor system is involved in the pathogenesis
of VILI. The blockade of ATP signaling might, therefore, be
a promising treatment of VILI.
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